JPMorgan has revealed its current stock picks in China, highlighting promising investment opportunities in various sectors. The banking giant advises investors to consider Tencent, the tech giant that continues to dominate the Chinese market with its innovative products. Additionally, JPMorgan recommends focusing on Alibaba, another tech behemoth that has made significant strides in e-commerce. In the healthcare sector, the bank suggests considering Mindray Medical, a leading manufacturer of medical devices. Furthermore, JPMorgan suggests exploring the potential of China Vanke, one of the largest real estate developers in the country. These stock picks offer investors a chance to capitalize on China's booming tech, e-commerce, healthcare, and real estate sectors.